GLP-1 Use May Benefit Shoulder Surgery Outcomes
Adults on GLP-1 therapy may see improved two-year outcomes after shoulder replacement, though further research is needed.
Updated on Oct. 27, 2026 in Diabetes
Live Poll
Do you trust emerging research to inform your expectations for successful surgical recovery?
A retrospective study using the global TriNetX database suggests that patients using GLP-1 receptor agonists may see improved outcomes two years after total shoulder arthroplasty. These preliminary findings, which analyzed data from 2008 to 2022, indicate potential differences in emergency care use and mortality for patients on the medication.
Why it matters
For patients considering joint replacement who also manage their health with GLP-1 medications, this data provides early insights into potential long-term postoperative outcomes. The research highlights the need for further prospective studies to confirm how these treatments influence recovery trajectories following major orthopedic surgery.
This retrospective study utilized one-to-one propensity score matching to compare outcomes among 1,917 patients in a 2-year cohort who underwent total shoulder arthroplasty. While the study found lower mortality and emergency department use in the treatment group, these results remain preliminary.
The details
Researchers examined surgical outcomes by comparing patients taking GLP-1 receptor agonists to a matched control group. The study specifically tracked postoperative benchmarks, including emergency department utilization and all-cause mortality, though it observed no significant differences in immediate 90-day medical complications or readmission rates between the two groups.
Timeline
2008-2022: Total shoulder arthroplasty procedures performed for study analysis.
- 2026-10-27
Date of article publication.
Health Landscape
This research contributes to the growing effort to understand how the widespread use of GLP-1 receptor agonists interacts with major surgical procedures. It adds a new layer to the standard of care for joint replacement, moving beyond immediate recovery to examine long-term patient health markers.
If you are scheduled for shoulder surgery and are currently taking a GLP-1 receptor agonist, consider discussing these findings with your orthopedic surgeon and primary care physician. Understanding how your medications might influence your post-surgical recovery is an important part of your care plan.
The takeaway
Patients on GLP-1 medications may experience different long-term recovery metrics following joint replacement surgery compared to those not on these therapies. Always consult your surgical team to review your current medication regimen and its potential influence on your specific orthopedic procedure.
Further reading
Learn more about the latest research and management strategies in our Diabetes section.
Live Poll
Do you trust emerging research to inform your expectations for successful surgical recovery?
